arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Author

Axel Petzold

5 papers · 2014–2025

2014: 12015: 12016: 02017: 02018: 12019: 02020: 02021: 02022: 02023: 02024: 12025: 1
2014peak 1 in 20142025

Frequent co-authors

Papers

showing 1–5 of 5 RSS

A standardized protocol for quantification of saccadic eye movements: DEMoNS

Jenny A. Nij Bijvank, Axel Petzold, Lisanne J. Balk +4 more

Human-Computer Interaction · PLoS ONE · · cited 54× · DOI ↗ · more like this ·

OBJECTIVE: Quantitative saccadic testing is a non-invasive method of evaluating the neural networks involved in the control of eye movements. The aim of this study is to provide a standardized and reproducible protocol for infrared oculography measurements of eye movements and analysis, which can be applied for various diseases in a multicenter setting. METHODS: Development of a protocol to Demonstrate Eye Movement Networks with Saccades (DEMoNS) using infrared oculography. Automated analysis methods were used to calculate parameters describing the characteristics of the saccadic eye movements. The two measurements of the subjects were compared with descriptive and reproducibility statistics. RESULTS: Infrared oculography measurements of all subjects were performed using the DEMoNS protocol and various saccadic parameters were calculated automatically from 28 subjects. Saccadic…

Partial Parallelism Plots

Axel Petzold

Statistics and Probability · Applied Sciences · · cited 2× · DOI ↗ · more like this ·

Demonstrating parallelism in quantitative laboratory tests is crucial to ensure accurate reporting of data and minimise risks to patients. Regulatory authorities make the demonstration of parallelism before clinical use approval mandate. However, achieving statistical parallelism can be arduous, especially when parallelism is limited to a subrange of the data. To address potential biases and confounds, I propose a simple graphical method, the Partial Parallelism Plot, to demonstrate partial parallelism. The proposed method offers ease of understanding, intuitiveness, and graphical simplicity. It enables the graphical assessment of quantitative data risk when parallelism is lacking within a defined range. As parallelism may not be consistent across the entire analytical range, the plots focus on partial parallelism. The method can readily be programmed into graphical applications for…

Neurofilaments: A Biomarker for Axonal Degeneration

Axel Petzold

Linguistics and Language · · cited 0× · OpenAlex ↗ · more like this ·

The aim of this chapter is to explain why Neurofilaments (Nf) are a useful biomarker for axonal degeneration and can be used as a surrogate endpoint in clinical and experimental research. 2 Definitions Neurofilaments: Nf are proteins which are exclusively expressed in neurons and their adjacent axons. Nf are particularly abundant in the axon, where they are key building blocks of the axonal cytoskeleton. The complex protein chemistry of Nf is briefly described. Biomarker: A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacological responses to therapeutic intervention. Surrogate endpoint : defines a biomarker that is intended to serve as a substitute of a clinically meaningful endpoint and is expected to predict the effect of a therapeutic intervention or the evolution of disease. 2…

G: Spectrophotometry for cerebrospinal fluid pigment analysis: a review. Neurocritical Care 2006

Axel Petzold, Lindsay T. Sharpe, Geoffrey Keir

Statistics and Probability · · cited 0× · OpenAlex ↗ · more like this ·

The use of spectrophotometry for the analysis of the cerebrospinal fluid (CSF) is reviewed. The clinically relevant CSF pigments — oxy-hemoglobin and bilirubin — are introduced and discussed with re-gard to clinical differential diagnosis and potentially confounding vari-ables (the four “T”s or: traumatic tap, timing, total protein and total bilirubin). The practical laboratory aspects of spectrophotometry and automated techniques are presented in the context of analytical and clinical specificity and sensitivity. The perceptual limitations of human color vision are highlighted and the use of visual assessment of the CSF is discouraged in light of recent evidence from a national audit in the United Kingdom. Finally, future perspectives including the need for longitudinal CSF profiling and routine spectrophotometric calibra-tion are outlined.

Parallelism in Neurodegenerative Biomarker Tests: Hidden Errors and the Risk of Misconduct

Axel Petzold, Joachim Pum, David P Crabb

q-bio.QM · · arXiv ↗ · more like this ·

Biomarkers are critical tools in the diagnosis and monitoring of neurodegenerative diseases. Reliable quantification depends on assay validity, especially the demonstration of parallelism between diluted biological samples and the assay's standard curve. Inadequate parallelism can lead to biased concentration estimates, jeopardizing both clinical and research applications. Here we systematically review the evidence of analytical parallelism in body fluid (serum, plasma, cerebrospinal fluid) biomarker assays for neurodegeneration and evaluate the extent, reproducibility, and reporting quality of partial parallelism. This systematic review was registered on PROSPERO (CRD42024568766) and conducted in accordance with PRISMA guidelines. We included studies published between December 2010 to July 2024 without language restrictions. ... In conclusion, partial parallelism was infrequently…